Middle East and Africa Allergy Immunotherapies Market Size and Competitive Analysis by 2027

The Middle East & Africa Allergy immunotherapies market was valued at US$ 137.87 million in 2019 and is projected to reach US$ 297.62 million by 2027; it is expected to grow at a CAGR of 10.2% during the forecast period.

The increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations are the key factors fueling the allergy immunotherapies market growth.

Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. This involves the regular administration of gradually increasing the dose of allergen extracts into the patient’s body over a certain period. The Allergy Immunotherapy market in the Middle East and Africa region is expected to exhibit the highest growth rate due to the increased incidence of allergy people in developing countries like Saudi Arabia and South Africa. In the recent report of the National Health and Nutrition Examination Survey, 54% of the population had positive test responses to one or more allergens. Allergic disorders are mostly treated with immunotherapy; thus, the growing prevalence of allergic diseases drives the growth of the market. Also, the growing unmet needs of novel targeted drugs, which are used to treat the allergic conditions, will create growth opportunities for the market players. Many companies are investing in research and development to develop targeted drugs for various allergic disorders.

The Covid-19 pandemic has harmed Middle East and Africa allergy immunotherapies market size, with small and medium scale companies struggling to sustain their businesses in the near-term future. Industry leaders are now focusing on creating new business practices to deal with crises like Covid-19 pandemic.

Middle East and Africa Allergy Immunotherapies Market Revenue and Forecast to 2027 (US$ Mn)

MIDDLE EAST AND AFRICA ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION

By Treatment

• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)

By Allergy Type

• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Country

• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Company Profiles

• HAL Allergy B.V.
• ALK Abello A/S
• Stallergenes Greer
• Anergis
• Circassia

Middle East and Africa Allergy Immunotherapies Report Scope